-
Gene expression adaptation of metastases to their host tissue
Study
EGAS50000000817
-
Recurrent/Metastatic Adenoid Cystic Carcinoma Treated with Axitinib and Avelumab
Study
EGAS50000001714
-
Genome-wide genotype data of 125 Agotes individuals presented in Portela-Estevez et al. 2026
Dataset
EGAD00010002839
-
RNA-seq and NGS target panel dataset related to "Ex vivo therapy-driven selection of glioblastoma stem-like cells models resistance evolution"
Dac
EGAC50000001111
-
Plasma cell‐free transcriptome profiling in chronic liver disease
Dac
EGAC50000000360
-
Genome-wide association study of never-smoking non-drinking young adults developing oral squamous cell carcinoma
Study
EGAS50000001809
-
an integrated molecular study of clear cell renal cell carcinoma (ccRCC) including whole-genome/exome and RNA sequencing as well as array-based gene expression/copy-number/methylation analyses
Study
EGAS00001000509
-
Spatial Transcriptomic data from Invasive lobular breast carcinoma (ILC)
Study
EGAS50000001735
-
Arcagen - Gynecologic cancer domain
Study
EGAS50000000900
-
Diverse Cellular Composition in Alveolar Rhabdomyosarcoma Revealed by Single Cell RNA Sequencing
Study
EGAS50000001564
-
Low intratumoral macrophage infiltration is a consistent immune microenvironment predictor of poor outcome in lymphoma patients treated with R-CHOP but not Pola-R-CHP
Study
EGAS50000001723
-
PTEN homozygous deletion is a negative prognostic factor in Tumor Treating Fields-treated glioblastoma, IDH wildtype patients
Study
EGAS50000001469
-
E-cadherin inactivation shapes tumor microenvironment specificities in invasive lobular carcinoma
Study
EGAS50000001760
-
Single-cell profiling of peripheral blood from treatment-naïve GBM patients and healthy donors.
Study
EGAS00001008497
-
Single-nucleus profiling of postmortem diffuse midline gliomas identifies mitochondrial biogenesis as a resistance mechanism to imipridone therapy
Study
EGAS50000001447
-
Arcagen - Skin cancer domain
Study
EGAS50000000491
-
Arcagen – Adrenal and Thyroid cancers domain
Study
EGAS50000000626
-
Arcagen - Head and Neck domain
Study
EGAS50000000625
-
Arcagen - Sarcoma domain
Study
EGAS50000000639
-
Djerroudi et al., E-cadherin inactivation shapes tumor microenvironment specificities in invasive lobular carcinoma
Study
EGAS50000000761
-
Inflammatory microenvironment impairs the therapeutic effect of daratumumab-lenalidomide in multiple myeloma
Study
EGAS00001008201
-
Tumor Profiler Ovarian Study
Study
EGAS50000000885
-
mRNA-seq of paired Follicular Lymphoma (FL) patient samples before and after high-grade transformation to DLBCL (FL vs. tFL) from FFPE tissues
Study
EGAS50000000941
-
Whole exome sequencing of pre-invasive lung adenocarcinoma in non-smokers
Study
EGAS50000000438
-
Upcycling and merging data to challenge the dogma and identify new therapeutic targets for Glioblastoma
Blog
upcycling-and-merging-data-to-challenge-glioblastoma
-
The last addition to the list of clonal evolution studies in the EGA
Blog
the-last-addition-to-the-list-of-clonal-evolution-studies-in-the-ega
-
Reading about genomic analysis of pan-neuroblastoma
Blog
genomic-analysis-of-pan-neuroblastoma
-
Drug development for pediatric cancers: the importance of patient' s genomic data re-use
Blog
drug-development-for-pediatric-cancers
-
Highlights from 2025: Our top 10 requested studies
Blog
top-10-studies-2025
-
Iberian Roma Data Access Commitee
Dac
EGAC00001002958
-
Oslo University Hospital Data Access Committee for REMNANT study datasets submitted to FEGA Norway
Dac
EGAC50000001121
-
Gut microbiota biomarkers associated with Multiple Myeloma: The REMNANT Study
Study
EGAS50000002142
-
scRNAseq data from HNSCC biopsies before and after BA treatment
Study
EGAS50000002114
-
CIML Lymphoma Single-Cell Atlas Project
Dac
EGAC50000001133
-
Norwegian Sarcoma Consortium Data Access Committee for datasets submitted to FEGA Norway
Dac
EGAC50000001153
-
NoSarC -- Norwegian Sarcoma Consortium. Towards individualized therapy for orphan cancer.
Study
EGAS50000002163
-
Cell-Free DNA Genomic and Fragmentomic Features for Early Outcome Prediction in Diffuse Large B-Cell Lymphoma
Study
EGAS50000000412
-
SCANDARE HNSCC
Study
EGAS50000001158
-
Orthotopic Patient-Derived Organoid Model Reveals Tumor Microenvironment-Dependent Phenotypes in Lung Squamous Cell Carcinoma-WTS
Study
EGAS50000002025
-
Orthotopic Patient-Derived Organoid Model Reveals Tumor Microenvironment-Dependent Phenotypes in Lung Squamous Cell Carcinoma-WGS
Study
EGAS50000002026
-
Orthotopic Patient-Derived Organoid Model Reveals Tumor Microenvironment-Dependent Phenotypes in Lung Squamous Cell Carcinoma-WES
Study
EGAS50000002027
-
Distinct molecular profiles characterize the spontaneous growth rate of IDHmt low-grade astrocytomas and oligodendrogliomas
Study
EGAS50000002072
-
Expansion and cytotoxicity of mucosal T cells in enterocolitis associated with BCMA CAR-T cell therapy
Study
EGAS50000002146
-
Additional medulloblastoma cfDNA low-coverage WGS
Study
EGAS50000002128
-
Germline whole-genome sequencing (WGS) of colorectal cancer patients
Dataset
EGAD50000002942
-
microRNA and isomiR profiling of Stage 1 epithelial ovarian carcinoma
Study
EGAS00001006617
-
Nanopore whole-genome sequencing of human sarcomas
Study
EGAS50000000651
-
Bladder cancer subtyping study across 4 atezo clinical trials
Study
EGAS50000000497
-
Nanopore Amplicon Sequencing data of 33 patient tumor and one primary cell line samples - all uveal melanoma
Study
EGAS50000002137
-
Cell-free DNA methylation profiling in classic Hodgkin lymphoma using cfEM-seq
Study
EGAS50000002038